UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 121

Sortiert nach

Drug Design: Where We Are and Future Prospects

Molecules (Basel, Switzerland), 2021-11, Vol.26 (22), p.7061

2021

Link zum Volltext

Verfügbarkeit prüfen

A Chemical Approach to Overcome Tyrosine Kinase Inhibitors Resistance: Learning from Chronic Myeloid Leukemia

Current medicinal chemistry, 2019-01, Vol.26 (33), p.6033

2019

Link zum Volltext

Verfügbarkeit prüfen

Selenoxide Elimination Triggers Enamine Hydrolysis to Primary and Secondary Amines: A Combined Experimental and Theoretical Investigation

Molecules (Basel, Switzerland), 2021-05, Vol.26 (9), p.2770

2021

Link zum Volltext

Verfügbarkeit prüfen

The Medicinal Chemistry of Natural and Semisynthetic Compounds against Parkinson’s and Huntington’s Diseases

ACS chemical neuroscience, 2017-11, Vol.8 (11), p.2356-2368

2017

Link zum Volltext

Verfügbarkeit prüfen

Antioxidant Potential of Psychotropic Drugs: From Clinical Evidence to In Vitro and In Vivo Assessment and toward a New Challenge for in Silico Molecular Design

Antioxidants, 2020-08, Vol.9 (8), p.714

2020

Link zum Volltext

Verfügbarkeit prüfen

New Therapeutic Applications of Phosphodiesterase 5 Inhibitors (PDE5-Is)

Current medicinal chemistry, 2016-05, Vol.23 (12), p.1239

2016

Link zum Volltext

Verfügbarkeit prüfen

Antioxidant Chimeric Molecules: Are Chemical Motifs Additive? The Case of a Selenium-Based Ligand

International journal of molecular sciences, 2023-07, Vol.24 (14), p.11797

2023

Link zum Volltext

Verfügbarkeit prüfen

A novel class of selective CK2 inhibitors targeting its open hinge conformation

European journal of medicinal chemistry, 2020-06, Vol.195, p.112267-112267, Article 112267

2020

Link zum Volltext

Verfügbarkeit prüfen

Effects of point mutations in the binding pocket of the mouse major urinary protein MUP20 on ligand affinity and specificity

Scientific reports, 2019-01, Vol.9 (1), p.300-300, Article 300

2019

Link zum Volltext

Verfügbarkeit prüfen

Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regression

Scientific reports, 2019-02, Vol.9 (1), p.1335-1335, Article 1335

2019

Link zum Volltext

Verfügbarkeit prüfen

Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2A

Blood, 2015-06, Vol.125 (24), p.3747-3755

2015

Link zum Volltext

Verfügbarkeit prüfen

Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2

Biochemical journal, 2009-07, Vol.421 (3), p.387-395

2009

Link zum Volltext

Verfügbarkeit prüfen

ROS-Scavenging Selenofluoxetine Derivatives Inhibit In Vivo Serotonin Reuptake

ACS omega, 2022-03, Vol.7 (10), p.8314-8322

2022

Link zum Volltext

Verfügbarkeit prüfen

Major Depressive Disorder and Oxidative Stress: In Silico Investigation of Fluoxetine Activity against ROS

Applied sciences, 2019-09, Vol.9 (17), p.3631

2019

Link zum Volltext

Verfügbarkeit prüfen

Targeted activation of the SHP-1/PP2A signaling axis elicits apoptosis of chronic lymphocytic leukemia cells

Haematologica (Roma), 2017-08, Vol.102 (8), p.1401-1412

2017

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of Selenium-Based Small Molecules Inspired by CNS-Targeting Psychotropic Drugs and Mediators

Chemistry an international journal, 2023-06, Vol.5 (3), p.1488-1496

2023

Link zum Volltext

Verfügbarkeit prüfen

2-(3,4-Dihydroxyphenyl)-4-(2-(4-nitrophenyl)hydrazono)-4H-chromene-3,5,7-triol

MolBank, 2020-09, Vol.2020 (3), p.M1144

2020

Link zum Volltext

Verfügbarkeit prüfen

Design, validation and efficacy of bisubstrate inhibitors specifically affecting ecto-CK2 kinase activity

Biochemical journal, 2015-11, Vol.471 (3), p.415-430

2015

Link zum Volltext

Verfügbarkeit prüfen

Coumarin as Attractive Casein Kinase 2 (CK2) Inhibitor Scaffold: An Integrate Approach To Elucidate the Putative Binding Motif and Explain Structure–Activity Relationships

Journal of medicinal chemistry, 2008-02, Vol.51 (4), p.752-759

2008

Link zum Volltext

Verfügbarkeit prüfen

Psychiatric Disorders and Oxidative Injury: Antioxidant Effects of Zolpidem Therapy disclosed In Silico

Computational and structural biotechnology journal, 2019-01, Vol.17, p.311-318

2019

Link zum Volltext

Verfügbarkeit prüfen

5-Hydroxy-3-(4-hydroxyphenyl)-8,8-dimethyl-6-(3-methylbut-2-enyl)pyrano[2,3-h]chromen-4-one

MolBank, 2018-09, Vol.2018 (3), p.M1004

2018

Link zum Volltext

Verfügbarkeit prüfen

Constrained bisantrene derivatives as G-quadruplex binders

ARKIVOC, 2016-02, Vol.2016 (3), p.145-160

2016

Link zum Volltext

Verfügbarkeit prüfen

Biological effects and potential mechanisms of action of Pistacia lentiscus Chios mastic extract in Caco-2 cell model

Journal of functional foods, 2019-03, Vol.54, p.92-97

2019

Link zum Volltext

Verfügbarkeit prüfen

Identification of Ellagic Acid as Potent Inhibitor of Protein Kinase CK2: A Successful Example of a Virtual Screening Application

Journal of medicinal chemistry, 2006-04, Vol.49 (8), p.2363-2366

2006

Link zum Volltext

Verfügbarkeit prüfen

9,10-Bis[(4-(2-hydroxyethyl)piperazine-1-yl)prop-2-yne-1-yl]anthracene: Synthesis and G-quadruplex Selectivity

MolBank, 2020-06, Vol.2020 (2), p.M1138

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 121

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)
Mit Volltextzugriff
(116)

Publikationsform

Artikel
(119)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Drug Design: Where We Are and Future Prospects

A Chemical Approach to Overcome Tyrosine Kinase Inhibitors Resistance: Learning from Chronic Myeloid Leukemia

Selenoxide Elimination Triggers Enamine Hydrolysis to Primary and Secondary Amines: A Combined Experimental and Theoretical Investigation

The Medicinal Chemistry of Natural and Semisynthetic Compounds against Parkinson’s and Huntington’s Diseases

Antioxidant Potential of Psychotropic Drugs: From Clinical Evidence to In Vitro and In Vivo Assessment and toward a New Challenge for in Silico Molecular Design

New Therapeutic Applications of Phosphodiesterase 5 Inhibitors (PDE5-Is)

Antioxidant Chimeric Molecules: Are Chemical Motifs Additive? The Case of a Selenium-Based Ligand

A novel class of selective CK2 inhibitors targeting its open hinge conformation

Effects of point mutations in the binding pocket of the mouse major urinary protein MUP20 on ligand affinity and specificity

Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regression

Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2A

Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2

ROS-Scavenging Selenofluoxetine Derivatives Inhibit In Vivo Serotonin Reuptake

Major Depressive Disorder and Oxidative Stress: In Silico Investigation of Fluoxetine Activity against ROS

Targeted activation of the SHP-1/PP2A signaling axis elicits apoptosis of chronic lymphocytic leukemia cells

Synthesis of Selenium-Based Small Molecules Inspired by CNS-Targeting Psychotropic Drugs and Mediators

2-(3,4-Dihydroxyphenyl)-4-(2-(4-nitrophenyl)hydrazono)-4H-chromene-3,5,7-triol

Design, validation and efficacy of bisubstrate inhibitors specifically affecting ecto-CK2 kinase activity

Coumarin as Attractive Casein Kinase 2 (CK2) Inhibitor Scaffold: An Integrate Approach To Elucidate the Putative Binding Motif and Explain Structure–Activity Relationships

Psychiatric Disorders and Oxidative Injury: Antioxidant Effects of Zolpidem Therapy disclosed In Silico

5-Hydroxy-3-(4-hydroxyphenyl)-8,8-dimethyl-6-(3-methylbut-2-enyl)pyrano[2,3-h]chromen-4-one

Constrained bisantrene derivatives as G-quadruplex binders

Biological effects and potential mechanisms of action of Pistacia lentiscus Chios mastic extract in Caco-2 cell model

Identification of Ellagic Acid as Potent Inhibitor of Protein Kinase CK2: A Successful Example of a Virtual Screening Application

9,10-Bis[(4-(2-hydroxyethyl)piperazine-1-yl)prop-2-yne-1-yl]anthracene: Synthesis and G-quadruplex Selectivity

Aktive Filter

Suchergebnisse filtern